Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.

This publication has 23 references indexed in Scilit:

• In Vitro Effects of the Platelet Glycoprotein IIb/IIIa Receptor Antagonist c7E3 Fab on the Activated Clotting Time
  Circulation, 1997
• Adhesion of platelets to surface-bound fibrinogen under flow
  Blood, 1996
• In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X.
  1996
• Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".
  Journal of Clinical Investigation, 1996
• Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18.
  1996
• Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
  Cell, 1996
• Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy
  Circulation, 1995
• Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine
  New England Journal of Medicine, 1995
• Thrombosis and Inflammation as Multicellular Processes: Significance of Cell-Cell Interactions
  Thrombosis and Haemostasis, 1995
• Platelets and Thrombolytic Therapy
  New England Journal of Medicine, 1990